BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen Q, Niu L, Hua C, Geng Y, Cai L, Tao S, Ni Y, Zhao R. Chronic dexamethasone exposure markedly decreased the hepatic triglyceride accumulation in growing goats. Gen Comp Endocrinol 2018;259:115-21. [PMID: 29155266 DOI: 10.1016/j.ygcen.2017.11.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Delanogare E, de Souza RM, Rosa GK, Guanabara FG, Rafacho A, Moreira ELG. Enriched environment ameliorates dexamethasone effects on emotional reactivity and metabolic parameters in mice. Stress 2020;23:466-73. [DOI: 10.1080/10253890.2020.1735344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Afshari AR, Sanati M, Aminyavari S, Shakeri F, Bibak B, Keshavarzi Z, Soukhtanloo M, Jalili-Nik M, Sadeghi MM, Mollazadeh H, Johnston TP, Sahebkar A. Advantages and drawbacks of dexamethasone in glioblastoma multiforme. Crit Rev Oncol Hematol 2022;:103625. [PMID: 35158070 DOI: 10.1016/j.critrevonc.2022.103625] [Reference Citation Analysis]
3 Xu L, Xia H, Ni D, Hu Y, Liu J, Qin Y, Zhou Q, Yi Q, Xie Y. High-Dose Dexamethasone Manipulates the Tumor Microenvironment and Internal Metabolic Pathways in Anti-Tumor Progression. Int J Mol Sci 2020;21:E1846. [PMID: 32156004 DOI: 10.3390/ijms21051846] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
4 Wang XY, Zhang LL, Jiang C, Hua BX, Ji ZF, Fan WS, Gong LJ, Zhu L, Wang XD, Yan ZQ. Altered lipidomic profiles in patients with and without osteonecrosis of the femoral head after 1-month glucocorticoid treatment. Clin Transl Med 2021;11:e298. [PMID: 33634986 DOI: 10.1002/ctm2.298] [Reference Citation Analysis]